Back to Search
Start Over
Association between TaqI A dopamine D[sub 2] receptor polymorphism and therapeutic response to bromperidol: a preliminary report.
- Source :
-
European Archives of Psychiatry & Clinical Neuroscience . 2001, Vol. 251 Issue 2, p57. 3p. - Publication Year :
- 2001
-
Abstract
- Abstract The relationship between TaqI A dopamine D[sub 2] receptor (DRD[sub 2]) polymorphism and therapeutic response to bromperidol, a selective dopamine antagonist, was investigated in 30 acutely exacerbated schizophrenic inpatients. Patients were treated with bromperidol 6-18 mg/day for 3 weeks. Clinical symptoms were evaluated by the Brief Psychiatric Rating Scale (BPRS) before and 3 weeks after the treatment. The TaqI A genotypes were determined with the PCR method. There was no significant difference in the percentage improvement of total BPRS or 5-subgrouped symptoms (positive, negative, anxiety-depression, excitement and cognitive symptoms) after the 3-week treatment between the patients with A1 alleles (n=18) and those with no A1 allele (n=12). Although the present study is preliminary, it is suggested that the TaqI A DRD[sub 2] polymorphism is not associated with therapeutic response to bromperidol in schizophrenic patients. [ABSTRACT FROM AUTHOR]
- Subjects :
- *DOPAMINE antagonists
*PEOPLE with schizophrenia
*MEDICAL care
Subjects
Details
- Language :
- English
- ISSN :
- 09401334
- Volume :
- 251
- Issue :
- 2
- Database :
- Academic Search Index
- Journal :
- European Archives of Psychiatry & Clinical Neuroscience
- Publication Type :
- Academic Journal
- Accession number :
- 4678484
- Full Text :
- https://doi.org/10.1007/s004060170053